病毒性肝炎与帕金森病的全国记录链接研究
该回顾性队列研究分析1999-2011年英格兰医院统计与死亡数据,比较乙型肝炎、丙型肝炎、自身免疫性肝炎、慢性活动性肝炎及HIV队列与参考队列的后续帕金森病发生率。结果显示乙型肝炎和丙型肝炎后帕金森病发生率显著升高,而其他肝炎及HIV无显著关联。
要点
- 乙型肝炎后帕金森病发生率比为1.76(95%CI 1.28-2.37,p<0.001)。
- 丙型肝炎后帕金森病发生率比为1.51(95%CI 1.18-1.9,p<0.001)。
- 自身免疫性肝炎、慢性活动性肝炎及HIV与后续帕金森病无显著关联。
核心结论
- 乙型肝炎和丙型肝炎患者后续帕金森病发生率显著升高。
研究设计与样本
- 回顾性队列研究,分析1999-2011年英格兰医院统计与死亡链接数据,构建乙型肝炎、丙型肝炎、自身免疫性肝炎、慢性活动性肝炎及HIV队列,与参考队列比较后续帕金森病发生率。
主要发现
- 乙型肝炎后帕金森病标准化率比为1.76(95%CI 1.28-2.37,p<0.001),基于44例观察 vs 25例预期。
- 丙型肝炎后帕金森病标准化率比为1.51(95%CI 1.18-1.9,p<0.001),基于48.5例预期 vs 73例观察。
- 自身免疫性肝炎、慢性活动性肝炎或HIV与后续帕金森病无显著关联。
- 仅纳入暴露后至少1年首次出现的帕金森病诊疗事件时,乙型肝炎和丙型肝炎的率比分别为1.82(95%CI 1.29-2.5)和1.43(95%CI 1.09-1.84)。
临床怎么用
- 对乙型肝炎或丙型肝炎患者,临床应关注帕金森病相关运动与非运动症状的监测。
局限性
- 病毒性肝炎与帕金森病关联的具体机制(感染后果、共享疾病机制或抗病毒治疗)尚待阐明。
- 需进一步研究确认该关联并探究病理生理通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study associations between viral hepatitis and Parkinson disease (PD). METHODS: A retrospective cohort study was done by analyzing linked English National Hospital Episode Statistics and mortality data (1999-2011). Cohorts of individuals with hepatitis B, hepatitis C, autoimmune hepatitis, chronic active hepatitis, and HIV were constructed, and compared to a reference cohort for subsequent rates of PD. RESULTS: The standardized rate ratio (RR) of PD following hepatitis B was 1.76 (95% confidence interval [CI] 1.28-2.37) (p < 0.001), based on 44 observed compared with 25 expected cases. The RR of PD following hepatitis C was 1.51 (95% CI, 1.18-1.9) (p < 0.001), based on 48.5 expected and 73 observed cases. There was no significant association between autoimmune hepatitis, chronic active hepatitis or HIV, and subsequent PD. When including only those episodes of care for PD that occurred first at least 1 year following each exposure condition, the RR for hepatitis B and hepatitis C were 1.82 (1.29-2.5) and 1.43 (1.09-1.84), respectively. CONCLUSIONS: We report strong evidence in favor of an elevation of rates of subsequent PD in patients with hepatitis B and hepatitis C. These findings may be explained by factors peculiar to viral hepatitis, but whether it reflects consequences of infection, shared disease mechanisms, or the result of antiviral treatment remains to be elucidated. Further work is needed to confirm this association and to investigate pathophysiologic pathways, potentially advancing etiologic understanding of PD more broadly.
引用
- Pakpoor J, Noyce A, Goldacre R, et al. Viral hepatitis and Parkinson disease: A national record-linkage study. Neurology. 2017. PMID: 28356465. doi:10.1212/WNL.0000000000003848
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。